Literature DB >> 2582047

Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies.

R W Hoffman, J A Bluestone, O Leo, S Shaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582047

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  13 in total

1.  Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.

Authors:  G Jung; C J Honsik; R A Reisfeld; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.

Authors:  S Koenig; P Earl; D Powell; G Pantaleo; S Merli; B Moss; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Glycosylation of the T-cell antigen-specific receptor and its potential role in lectin-mediated cytotoxicity.

Authors:  S C Hubbard; D M Kranz; G D Longmore; M V Sitkovsky; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.

Authors:  M A Liu; D M Kranz; J T Kurnick; L A Boyle; R Levy; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

7.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

9.  Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.

Authors:  M B Moreno; J A Titus; M S Cole; J Y Tso; N Le; C H Paik; T Bakács; C M Zacharchuk; D M Segal; J R Wunderlich
Journal:  Cancer Immunol Immunother       Date:  1995-03       Impact factor: 6.968

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.